RA
OPNT

Ramius Advisors’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Ramius Advisors’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55,298
Closed -$1.12M – 162
2022
Q4 		$1.12M Buy
+55,298
New +$848K 1.07% 15

Ramius Advisors's OPNT Position: Q1 2023 in Review

Ramius Advisors sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 55,298 shares — an estimated $1.12M sold.

Ramius Advisors first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $1.12M in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

  • Ramius Advisors reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ramius Advisors sold 55,298 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $1.12M.
  • Ramius Advisors first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Ramius Advisors's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $1.12M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Ramius Advisors's 13F filing for Q1 2023, filed 11 May 2023.